TwinBeech Capital’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$260K Buy
+24,280
New +$272K 0.06% 327
2021
Q3
– Sell
-19,901
Closed -$415K – 677
2021
Q2
$415K Buy
+19,901
New +$494K 0.05% 330

Other funds holding KURA

TwinBeech Capital's KURA Position: Q3 2026 in Review

TwinBeech Capital opened a new position in Kura Oncology (KURA) in Q3 2026: 24,280 shares worth $260K. The stake represents 0.06% of the portfolio and ranks #327 among its holdings. This is a return to the name: TwinBeech Capital previously reported a position in KURA as recently as Q2 2021.

TwinBeech Capital first reported a position in KURA in Q2 2021 and has held it in 2 quarters since. The position peaked at $415K in Q2 2021. 233 funds tracked by Wall St. Rank hold KURA as of Q3 2026.

  • TwinBeech Capital held 24,280 shares of Kura Oncology worth $260K as of Q3 2026.
  • Kura Oncology was a new TwinBeech Capital position in Q3 2026.
  • Kura Oncology made up 0.06% of TwinBeech Capital's portfolio in Q3 2026, its #327 holding.
  • TwinBeech Capital first reported a position in Kura Oncology in Q2 2021 and has held it in 2 quarters since.
  • TwinBeech Capital's Kura Oncology position peaked at $415K in Q2 2021.
  • 233 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2026.

Based on TwinBeech Capital's 13F filing for Q3 2026, filed 16 Nov 2026.